One year immunogenicity and safety of subunit plague vaccine in Chinese healthy adults: An extended open-label study.

Background: To evaluate the one-year immunogenicity and safety of a subunit plague vaccine.

Methods: In the initial study, 240 healthy adults aged 18-55 years were administrated with 2 doses of 15 or 30 µg plague vaccines at day 0 and 28, respectively. In this extended follow-up study, we evaluated the immunogenicity and safety of the plague vaccine up to one year.

Identification of the pXO1 plasmid in attenuated Bacillus anthracis vaccine strains.

Anthrax toxins and capsule are the major virulence factors of Bacillus anthracis. They are encoded by genes located on the plasmids pXO1 and pXO2, respectively. The vaccine strain Pasteur II was produced from high temperature subcultures of B.